Previous Article | Next Article 
Journal of Virology, November 1999, p. 9256-9265, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Genetic Stability of Foamy Viruses: Long-Term Study
in an African Green Monkey Population
Matthias
Schweizer,*
Hubertus
Schleer,
Michael
Pietrek,
Jürgen
Liegibel,
Valeria
Falcone, and
Dieter
Neumann-Haefelin
Abteilung Virologie, Institut für
Medizinische Mikrobiologie und Hygiene, University of Freiburg,
Freiburg, Germany
Received 13 May 1999/Accepted 2 August 1999
 |
ABSTRACT |
The genetic variability of the envelope surface domain (SU) of
simian foamy virus (FV) of African green monkeys was studied. To assess
the interindividual diversity of FV, isolates were obtained from 19 animals living together in a monkey house. The monkeys had been
imported from Kenya prior to being placed in long-term housing in the
research institute. In addition, a simian FV isolate and proviral DNA
were obtained from an animal caretaker infected in this setting. DNA of
the complete SU (1779 to 1793 bp) was analyzed by PCR and sequencing.
The sequences revealed four clusters with high homologies (>95%).
Between the clusters, divergencies ranged from 3 to 25%. Obviously,
the clusters reflect four different strains or subtypes of simian FV
type 3 that were prevalent in the colony. In contrast to lentiviruses,
hypervariable regions could not be detected in the FV SU. Furthermore,
to analyze the intraindividual diversity of FV, we investigated the
virus population within an individual monkey at a given time point and
its evolution over 13 years. For this purpose, 22 proviral SU clones
generated by PCR from one oral swab and seven isolates obtained from
the same animal between 1982 and 1995 were examined. These sequences revealed exceptionally high homology rates (99.5 to 100%), and only a
minimal genetic drift was recognized within the series of isolates. In
conclusion, the low in vivo divergency of FV SU suggests that genetic
variability is not important for the maintenance of FV persistence.
 |
INTRODUCTION |
Genetic variability of various
viruses is thought to be instrumental in viral persistence in vivo. In
particular, the extraordinarily high variability of lentiviruses, like
human and simian immunodeficiency viruses (HIV and SIV, respectively),
results in the rapid development of a complex viral quasispecies. It
has been proposed that genetic variability might counteract host immune
reactions, for example by generating viral escape mutants
(3) or by exceeding a threshold of antigenic diversity
beyond which the immune system cannot cope (31). However,
these hypotheses have not been confirmed by recent reports (20,
32), and the role of variability in viral persistence and in the
development of disease is discussed controversially (45).
Retroviruses of the human T-lymphotropic virus/bovine leukemia virus
(HTLV/BLV) group (Deltaretrovirus genus) reveal very stable
genomes in vivo (13), questioning the assumption that
genetic variability is essential for retrovirus persistence. However,
substantial data on intra- and interanimal genetic variation of
retroviruses other than the primate lentiviruses or members of the
HTLV/BLV group are missing (45).
In this study, we analyzed the genetic variability of foamy viruses
(FV; Spumavirus genus of the Retroviridae family
[18]), which are complex retroviruses utilizing a
replication cycle that shares features of retro- and hepadnaviruses
(25, 34, 49), both prone to genetic variability. FV cause
persisting infections in various mammalian species and are prevalent at
high rates in nonhuman primates (29). Early reports on FV
prevalence in the general human population could not be confirmed
(1, 40). However, human infections resulting from accidental
transmissions of nonhuman primate FV are well documented (16, 29,
41). FV pathogenicity does not occur in naturally and
experimentally infected animals nor in accidentally infected humans.
This points to a highly host-adapted mode of persistence. Developmental
deficits in FV-transgenic mice have been described (4), but
the relevance of these findings for the natural course of infection is questionable.
The degree of the genomic variability of FV in vivo is not known at
present. Only four complete sequences of FV isolates from different
primate species are available and can be compared. Small portions
(e.g., from the pol region [38]) that were
obtained by PCR from FV isolates or from peripheral blood lymphocyte
(PBL) samples of infected primates have been used to compute
phylogenetic relationships of various primate FV. However, up to now
the genomic diversity of viruses within one species has been analyzed
exclusively by Southern blot hybridization of isolates from one monkey
colony (39), and data on variability within an infected
individual are completely missing. Therefore, we analyzed the genomic
variability of the FV present in a stable colony of African green
monkeys (AGM) and in a single animal of this colony. We decided to
focus our work on the complete surface domain (SU) of the
env gene for several reasons. (i) SU is the major target for
antiviral immunity, and highest degrees of variability can be expected
in this region. (ii) Most variability studies in other retroviruses
have been done on SU sequences, facilitating comparison of data. (iii)
Sequencing of complete domains minimizes the risk of overlooking
hypervariable regions.
According to our results, the genomic variability of FV within one
animal appears to be too low to play an essential role for viral
persistence but does allow distinct FV strains within one monkey
species to be defined.
 |
MATERIALS AND METHODS |
Animals.
All AGM (Chlorocebus
[Cercopithecus] aethiops) investigated in this
study had been caught in the wild in Kenya and kept in single cages at
the Department of Virology in Freiburg, Germany, ever since (Table
1).
Virus isolation.
Isolation of FV from the oral mucosa of AGM
has been described previously (41). Briefly, human diploid
fibroblasts (strain alpha-1) were inoculated with throat swab material
freshly obtained from FV-seropositive monkeys and cultivated until
typical FV cytopathic effect occurred. Infection was proven by indirect
immunofluorescence by using FV-positive AGM sera (30) and
FV-specific pol PCR (38).
PCR.
Infected cell cultures of freshly obtained throat swab
material were lysed by sarcosyl, and DNA was isolated by
phenol-chloroform extraction as described previously (37).
The whole SU was amplified by nested PCR with primer sequences from
segments next to SU which have been found to be highly conserved in all
published sequences of primate FV (human FV [HFV]
[11], simian FV from chimpanzees [SFVcpz]
[17], SFV type 1 [SFV-1] [22], and
SFV-3/LK-3 [33]). The primers for the outer PCR were
pM3, 5'-GGCCAATTAGTCCAGGAGAGGGT-3' (nucleotides 6911 to 6933 in SFV-3/LK-3 [33]), and pMA4,
5'-CTTCCATCAAAGTGACAACATGATC-3' (nucleotides 9017 to 8994),
and the primers for the inner PCR were pM1,
5'-ATTTTGGACCATCTTGGCAACA-3' (nucleotides 7013 to 7034), and
pM2 (nucleotides 8836 to 8814). Amplification conditions have been
previously described (38).
Cloning and sequencing of the amplification products.
Amplification products were cloned by using a TA cloning kit
(Invitrogen, San Diego, Calif.) and sequenced by the dideoxy chain
termination method by using USB DNA sequencing kit 2.0 (U.S. Biochemicals, Cleveland, Ohio), as recommended by the suppliers. The
following oligonucleotides were used as primers for sequencing: SP6 and
T7, located on the TA vector and flanking the cloned amplification product; pM1 and pM2, which had been used for PCR; and p1 to p9, located in the amplification product (Fig.
1) generated according to the ongoing
sequencing results. Primer sequences and positions on the resulting
consensus sequence were as follows: for p1, CGCGTGTTATGTGTTGGT (nucleotides 245 to 262); for p2, CCTGTTTCGTTACTATTGCTA
(nucleotides 302 to 322); for p3, GTTACTCATCAGGCCACATACC
(nucleotides 376 to 397); for p4, GTCTAGCATACCACAAGGTG
(nucleotides 474 to 493); for p5, CCTCTAGGAGATCCTAGAGATC
(nucleotides 685 to 706); for p6, CATGTGCTATTCTGTTCTGATC (nucleotides 988 to 1009); for p7, TCCACAGTCTCCTTCCCA
(nucleotides 1266 to 1249); for p8, CAAAGTGGTGATGGAAATGC
(nucleotides 1511 to 1492); and for p9, AAGCCCTAGCTGTAGGGAT
(nucleotides 1678 to 1660).

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 1.
Genomic organization of AGM FV. The region investigated
is enlarged. Oligonucleotides used as PCR primers (pM1 and pM2) or
sequencing primers (p1 to p9) are indicated by arrows. The exact
positions are given in Materials and Methods. LTR, long terminal
repeat.
|
|
Sequence analysis.
Only the sequences between the PCR
primers, spanning the region of the pol/env overlap, the
complete SU, and the beginning of the transmembrane region (TM) were
analyzed by using different software packages of HUSAR (Heidelberg Unix
Sequence Analysis Resources). CLUSTALW (43) was used for
multiple sequence alignments. Similarity plots were generated by
PlotSimilarity, which calculates the average similarity among all
members of a group of aligned sequences at each position in the
alignment. The symbol comparison table used was plotsimpep.cmp, which
has a similarity score of 1.5 for perfect symbol matches. Pairwise
homology rates were calculated by Homologies; the symbol comparison
table used for the estimation of amino acid sequence similarity was
comparpep.cmp; for amino acid identity, uniquepep.cmp; and for nucleic
acid homology, compardna.cmp. Phylogenetic analysis was performed with
PHYLIP version 3.5 (9). Evolutionary distances were
calculated by DNAdist by using Kimura's two-parameter method
(21); phylogenetic relationships and trees were computed
from the distance matrix by KITSCH by using the Fitch-Margoliash
method, version 3.572c (10), or by Neighbor by using the
neighbor-joining method (36).
Nucleotide sequence accession numbers.
The nucleotide
sequences of the 50 AGM FV SU sequences obtained in this
study have been submitted to the EMBL Nucleotide Sequence Database
under accession no. AJ244067 to AJ244116.
 |
RESULTS |
Characterization of the env SU of FV from different
individuals.
From 1982 to 1994, simian FV isolates were obtained
from oral swabs of 19 animals living in a closed AGM colony. A recent simian FV isolate and proviral DNA from PBL of an animal caretaker were
included in the study, since the infection had originated from an
animal of this colony, probably transmitted by a bite in 1976 (38,
41). Furthermore, the AGM FV prototype SFV-3, which had been
isolated before 1964 from an AGM kept in New York (42), was
analyzed for comparison. The features of all FV investigated in this
study are listed in Table 1. Proviral DNA of infected cells was
amplified by a nested PCR with highly conserved primers flanking the SU
of the FV env gene (Fig. 1). Amplification products were
cloned and sequenced with the sequencing primers shown in Fig. 1. The
nucleotide sequences were aligned by comparing them with the published
sequence for SFV-3/LK-3 (an AGM FV isolated before 1978 from a lymph
node of another animal of this colony [30, 33]) and
other published sequences of primate FV prototypes (Table
2 and data not shown). The respective
amino acid alignment is shown in Fig.
2.


View larger version (121K):
[in this window]
[in a new window]
|
FIG. 2.
Multiple amino acid sequence alignment of the SU regions
of the FV listed in Table 1, generated by CLUSTAL. Highly conserved
sequence motifs are indicated. All variant glycosylation sites are
emphasized by bold letter. C, cysteines; ***, N-glycosylation
sites (N-Xaa-S/T); cleavage, cleavage site between SU and TM.
|
|
All sequences contained an intact SU open reading frame. The lengths of
the amplification products varied from 1779 to 1794
bp; the differences
correspond to insertions or deletions of amino
acids in the 3' region
of SU. The first ATG in the
env open reading
frame is
located at positions 49 to 51 of the amplification products.
Sequences
coding for a motif similar to a subtilisin-like protease
cleavage site
typically placed between the SU and TM of retroviruses
(R-X-K/R-R
[
46]) were found downstream of either nucleotide
1737 or 1752. Thus, the sizes of the SUs of the different FV range
from 563 to 568 amino acids. Within SU, the predicted cleavage
site C/F behind
the putative signal peptide (
46) at amino acid
positions 86 and 87 as well as the positions of 11 glycosylation
sites (N-X-S/T
[
44]) and 18 cysteines are highly conserved,
pointing
to an essential role of these motifs (Fig.
2). Remarkably,
the
positions of glycosylation sites 1 to 4, 7, 10, and 11 are
completely
conserved, whereas the positions of sites 5, 6, 8,
and 9 differ by
several amino acids in some of the sequences.
In detail, site 5 of
SFVcpz and HFV is shifted by two amino acid
positions, versus all other
sequences, and site 6 of SFV-1 is
shifted by five amino acid positions.
Sites 8 of the AGM isolates
of group 2 and of SFV-1 are shifted by five
amino acids. Sites
9 of AGM isolates of group 2 and of SFV-1, SFVcpz,
and HFV are
positioned 10 amino acids downstream of sites 9 of the AGM
isolates
of group
1.
Phylogenetic analysis of FV from different individuals.
Pairwise alignments of the SU sequences showed various degrees of
genetic homologies. FV from AGM could be divided into two main groups,
which were again composed of minor clusters (A to D) with sequence
homologies of more than 95%. Remarkably, cluster B contained two
pairs of 100% identical amino acid sequences (pair agm6 and agm16 and
pair agm3 and agm4). In the phylogenetic tree established by the PHYLIP
program, these groups and clusters can easily be distinguished (Fig.
3). The range of the pairwise homology rates within each cluster or between the different clusters is shown in Table 3. Remarkably, the first
group (comprising clusters A and B and SFV-3/LK-3) contains all
sequences with the smallest SU, i.e., 563 amino acids. All isolates of
this group (except SFV-3/LK-3) originate from monkeys which had been
obtained by two shipments in July 1979 and October 1980. All sequences
of the second group (clusters C and D) revealed 568 amino acids. Host
monkeys of these isolates had been delivered earlier than the previous
ones, with the exception of agm17 which had also been shipped in
October 1980. The sequence SFVhum derived from PBL of the infected
animal caretaker is 99.3% (98.8% at the amino acid level) homologous
to the respective isolate SFVka; these two sequences, together with the
sequence agm20, form cluster D. The AGM sequence SFV-3 (which does not
originate from this colony) has 567 amino acids and is about 82%
homologous to clusters C and D but only about 71% homologous to
clusters A and C. Nevertheless, the homology of SFV-3 to any FV of this
AGM colony is higher than that to FV from other species (Fig. 3). The
range of pairwise homologies between all AGM sequences and SFV-1 or
SFVcpz/HFV is also shown in Table 3.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
Phylogenetic tree of the FV investigated, compiled by
CLUSTAL and PHYLIP programs (DNAdist and KITSCH). Resulting clusters
and groups are indicated. Sequences compiling the clusters are not
labeled.
|
|
The sequence variability found in this colony was analyzed in detail.
The two major groups differ in length by 5 amino acids
which are
present only in the sequences of the second group (clusters
C and D). G
and T are found at amino acid positions 351 and 352,
and N, E, and S
are found at amino acid positions 424 to 426.
Furthermore, AGM
prototype SFV-3 differs from the sequences of
the second group in that
it is missing one lysine at the beginning
of the cleavage site.
Moreover, analysis of single base exchanges
(in addition to the amino
acid insertions described) revealed
that, altogether, 3,004 substitutions against the consensus sequence
are present in the 22 FV
sequences derived from this colony; 974
of them (32.4%) resulted in
amino acid
exchanges.
Figure
4 shows a similarity plot of the
16 amino acid sequences of the first group of AGM FV (clusters A and B
and SFV-3/LK-3).
It emphasizes the homogeneous distribution of variant
amino acids
over the entire SU; deviations of up to 5% were not
concentrated
in a hot spot. Thus, the SU of FV from AGM does not
contain a
hypervariable region. A similarity plot of all AGM FV,
including
the six sequences of the second group, and SFV-3 simulated a
peak
of variability in the 3' region of SU which corresponds to the
insertions described (not shown).

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 4.
Similarity plot of the amino acid sequences of the FV
isolates of group 1. The symbol comparison table used was
plotsimpep.cmp, which has a similarity score of 1.5 for perfect symbol
matches.
|
|
Genomic variability of the FV population within a single AGM.
To monitor FV sequence variation over the lifetime of one animal, seven
FV isolates were obtained from animal no. 1 (AGM1) at six time points
between 1982 and 1995 (Table 4). To
investigate the virus population without selection of cell
culture-adapted strains, DNA was extracted directly from one defined
throat swab that also gave rise to isolates agm1-95a and agm1-95b
(isolates obtained in 1995) by parallel cultures. After PCR and cloning of the amplification products, 22 clones (ra28 to ra57) originating from one ligation reaction were analyzed as described previously.
Multiple alignment of all SU nucleotide sequences from this animal
(data not shown) revealed highly conserved sequences: all
of them were
more than 99.5% homologous, and two of them were
identical.
Interestingly, these two identical sequences were ra46
(one proviral
clone from the 1995 throat swab) and agm1-94a (an
isolate obtained in
1994), whereas the two isolates obtained simultaneously
in 1995 from
the same throat swab were different. Each sequence
revealed between one
and five substitutions, compared to the consensus
sequence. The
multiple amino acid sequence alignment is shown
in Fig.
5. Minimal variability
was found homogeneously distributed
over the SU segment with one
exception: at nucleotide position
1031, four sequences (ra28, -30, -31, and -33) revealed the same
substitution of A to G, resulting in an
amino acid exchange from
N to S (amino acid position 328). Altogether,
64 substitutions
were located in 29 sequences represented by a total of
51,591
bases. Thirty-five substitutions (55%) were nonsynonymous; two
of these resulted in stop codons (amino acid positions 147 in
ra57 and
108 in agm1-91). At the amino acid level, one pair and
one group of
five identical sequences were detected (pair ra30
and ra31 and group
ra43, ra46, ra51, ra55, and agm1-94a).


View larger version (104K):
[in this window]
[in a new window]
|
FIG. 5.
Multiple amino acid sequence alignment of the SU regions
of the proviral clones and isolates obtained from agm1, generated by
CLUSTAL. , stop codons in agm1-91 and ra57; C, cysteines; ***,
N-glycosylation sites (N-Xaa-S/T); cleavage, cleavage site between SU
and TM.
|
|
The sequence agm1-95a was used for the analysis of FV isolates from
different monkeys and was found to fit into cluster B
(Fig.
3). A
dendrogram of the nucleotide sequences from cluster
B, including all
sequences from AGM1 (Fig.
6), shows that
the
sequences from AGM1 form a subcluster within cluster B. The
isolates
taken from AGM1 at different time points are distributed
randomly
over the whole cluster of proviral clones obtained directly
from
the throat swab; only the two oldest isolates (from 1982 and 1990)
and two of the proviral clones (ra42 and ra57) were minimally
separated
from all other sequences from AGM1. Thus, only a minimal
genetic drift,
if any, could be detected from 1982 to 1991, whereas
no drift could be
recognized between 1991 and 1995.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 6.
Dendrogram of the SU nucleotide sequences of cluster B,
including all sequences obtained from agm1 (shadowed box), compiled by
CLUSTAL and PHYLIP programs (DNAdist and KITSCH).
|
|
To define the background of substitutions due to PCR, cloning, and
sequencing artifacts, a molecular clone of SU was amplified,
cloned,
and sequenced by the same methods used for all other isolates
and the
throat swab. Twenty clones originating from the same ligation
reaction
were analyzed by sequencing the region between nucleotides
1000 and
1500 (data not shown). Within approximately 10,000 nucleic
acids
sequenced, only two substitutions were detected. This background
is in
the range of the error rate described for the employed
Taq polymerase (
19). Therefore, the minor variability found in
the
FV sequences from AGM1 (64 substitutions in 51,591 bases or 12
in
10,000 bp) was about sixfold higher than the inaccuracies of
the
amplification, cloning, and sequencing system
used.
 |
DISCUSSION |
Primate FV reveal a particular mode of persistence characterized
by apathogenicity in vivo in spite of severe cytopathogenicity in cell
culture. To elucidate the role of FV genetic variability in the
establishment and maintenance of persistence, we compared the FV SU
sequences occurring in the population of an AGM colony and in an
individual animal. It is known that FV of different primate species
(chimpanzee, rhesus monkey, and AGM) reveal considerable (type-defining) sequence differences with the highest divergencies in
the gag gene (46). Thus, comparing sequences
obtained from different species was not the goal of this study.
Phylogenetic analysis of isolates from different AGM living in a closed
colony revealed different clusters of FV addressable as strains and
subtypes of AGM FV (Fig. 3). For example, clusters A to D might be
designated as strains, and groups 1 and 2 might be designated as
subtypes. The divergence between groups 1 and 2 ranged between 22 and
25%; this value is on the same order of magnitude as that reported for
comparable genome segments of different subtypes of HIV or SIV
(27) but significantly higher than that of subtypes of
simian T-lymphotropic virus type 1 or 2 or HTLV type 1 or 2, which is
8% at most (13, 15). Obviously, genetic variability of FV
has been sufficient to generate highly divergent strains within one
species. On the other hand, the divergency within the strains or
cluster A, B, or C is less than 1.2%, which is much lower than that
reported for HIV or SIV (up to 15% [27]). Within
cluster D, divergency is about 5%, pointing out how arbitrary an
attempt to classify the clusters as strains or subtypes would be.
Unfortunately, the period of time required to reach a certain level of
diversity remained undefined since the time point and source of
infection of each monkey are unknown. However, the phylogenetic tree
proves that only a few strains have spread in this colony, as the
homology rates within one cluster are remarkably high. It can be
speculated that infection of the monkeys occurred before delivery to
our institute, maybe in wild-living clans before capture or during
transport; in fact, the animals had usually been kept in single cages
in the final colony to avoid biting, which is considered to be the mode
of primate FV transmission. Furthermore, the different clusters are
associated with different capture and purchase dates of monkey herds:
clusters A and B originate from monkeys obtained in July 1979 or
October 1980, whereas the host monkeys of subtypes C and D (except
isolate agm17) had been delivered between 1975 and February 1979. This
interpretation of the phylogenetic tree is confirmed by the two
sequences originating from the infected animal caretaker: they are
closely related to AGM isolate agm20 obtained from a monkey that had
been delivered in 1975, which is in accordance with the time of
infection of the worker by a monkey bite in 1976 (41).
Interestingly, agm17 had been obtained in 1980 but belongs to the
earlier cluster C. This may be explained by infection in our institute,
because housing in single cages was temporarily interrupted for
experimental procedures or occasional breeding attempts.
To interpret the degree of sequence variability, only closely related
viruses should be analyzed, as the comparison of nonrelated sequences
may lead to overinterpretation of local or overall variability rates
(45). Therefore, only clusters A and B were compared to identify hypervariable regions in the FV SU region. The high homology rates of more than 96% between isolates of this group point to common
ancestors. Moreover, all sequences of clusters A and B reveal the same
length of SU, whereas the main difference from group 2 is the insertion
of 5 amino acids which would mimic hypervariable regions. However, the
similarity plot of group 1 (Fig. 4) clearly revealed that hypervariable
regions comparable to the five variable loops in the HIV type 1 gp120
do not exist in FV. Hypervariability in the immunodominant loops of HIV
type 1 is considered as the prerequisite for the emergence of immune
escape mutants (3). Such a mechanism is obviously not used
by AGM FV. The difference between FV and HIV is illustrated by
differences in the ratio of nonsynonymous versus synonymous
substitutions: a ratio significantly greater than 1 is supposed to be
indicative of positive selection for sequence changes (23,
24). In all AGM FV analyzed, the actual figure of the ratio was
0.48, which is in the range expected for random mutations or even for
selection against mutations (23, 24). In contrast, HIV
reveals ratios of nonsynonymous versus synonymous changes of up to 2.9 (23, 24), which implies positive selection of changes, at
least within particular hypervariable domains.
To further compare the degree of intrahost genetic diversity of FV to
that of other retroviruses, a cross-sectional sample of virus produced
in one animal at one time point was investigated. Nucleic acid analysis
was applied directly to a throat swab without virus isolation avoiding
selection of cell culture-adapted variants. Throat mucosa is the
exclusive site where viral replication has been detected in naturally
infected primates (8). PCR was done without previous reverse
transcription of RNA, since besides intracellular proviral genomes
sufficient DNA is also present in virions (25). Sequencing
of 20 molecular clones originating from one PCR has been considered to
be sufficient to detect variants forming at least 10% of the virus
population present in the respective sample (26). The
divergency of 0.5% found between the 22 molecular clones obtained from
one oral mucosa sample is very low but significant, indicating that the
recovered variants indeed represent the range of genetic divergency of
FV within this organ. This divergency is in the same range as that
described for viruses of the HTLV/BLV group (<0.5%
[13]) but considerably lower than that for lentivirus, which reaches 12% divergency at amino acid level within one host (5). Furthermore, absence of hypervariable regions and the low proportion of nonsynonymous substitutions again argue against a
role of variability in the establishment of viral persistence, as
already shown above for isolates from different monkeys. The two stop
codons detected in isolate agm1-91 and in the proviral clone ra57 may
be due to PCR artifacts or nonfunctional DNA present in cell culture or
in the throat swab sample, respectively.
Interestingly, viral isolates from various time points between 1991 and
1995, including two distinguishable isolates from the swab used for
generation of proviral clones, maintain the same range of sequence
differences as the clones (Fig. 6). The fact that the virus population
reveals this high degree of homogeneity indicates that sequence
alterations due to cell culture adaptation can be neglected and any
isolate represents proviral and viral population at the time point of
isolation. Furthermore, no genetic drift could be recognized between
1991 and 1995. Only from 1982 to 1991 has a minimal drift of about
0.3% occurred, suggesting a variability rate of about 3 × 10
4 per site per year (six base substitutions per 1,779 bp per 9 years). This is slightly higher than that reported for the
HTLV/BLV group (10
4 for BLV [48] and
HTLV type 1 [12]) but much lower than that of
lentiviruses, which ranges between 10
2 and
10
3 (14).
In conclusion, genetic variability of FV is sufficient to generate
highly divergent strains in different species and also different
strains within one primate species but probably too low in individual
hosts to be instrumental in viral persistence. There may be different
reasons for this degree of stability. In general, the amount of genetic
variability of a gene is determined by the mutation rate and either
positive or negative selection pressure. The mutation rate depends on
the error rate of nucleic acid polymerases and on the replication rate.
The fidelity of FV reverse transcriptase is not known. However, it has
been argued that the mutation rate is the least important aspect of
viral variation (6, 32, 45), since it is in the same range
for all retroviruses tested (including the extraordinarily stable HTLV). Therefore, the most important factor may be the replication rate. For HIV and SIV, the high genomic variability has been
reported to be due to the extraordinary high rates of viral replication in the host (7, 45), whereas the stability of HTLV/BLV has been explained by its low replication rate (47). The latter explanation is probably also true for FV, since the replication rate of
FV is very low in infected monkeys: only low levels of viral RNA can be
detected in the oral mucosa but not in other FV DNA-positive tissues,
including blood cells (8). Finally, selection pressure may
be considered: positive selection of variants could emerge from immune
pressure, while negative selection might be favored by functional
constraints. The low ratio of nonsynonymous against
synonymous substitutions points to random mutation or even
negative selection, preventing any changes (23, 24). This
clearly contradicts the hypothesis that variability in the SU
region might play an essential role for FV persistence.
Taken together, compared to lentiviruses, the genome of FV was
found to be very stable, probably due to the low replication rate of FV
in vivo and to missing selection pressure for sequence changes.
Therefore, the probability of biological changes, e.g., expansion
of pathogenic potential or host range, can be considered low for FV.
From a practical point of view, the genetic stability proven by these
investigations may encourage efforts to develop FV vectors for human
gene therapy (2, 28, 35).
 |
ACKNOWLEDGMENTS |
We thank Otto Haller for continuous support and critical reading
of the manuscript.
This work was supported by the Deutsche Forschungsgemeinschaft, grant
Ne 213/5-1, and by the EC, grant BMH4-CT 97-2010 in the BIOMED 2 program.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Abteilung
Virologie, Institut für Medizinische Mikrobiologie und Hygiene,
Hermann-Herder-Str. 11, D-79104 Freiburg, Germany. Phone: 49 761 203-6619. Fax: 49 761 203-6634. E-mail:
mschweiz{at}ukl.uni-freiburg.de.
 |
REFERENCES |
| 1.
|
Ali, M.,
G. P. Taylor,
R. J. Pitman,
D. Parker,
A. Rethwilm,
R. Cheingsong-Popov,
J. N. Weber,
P. D. Bieniasz,
J. Bradley, and M. O. McClure.
1996.
No evidence of antibody to human foamy virus in widespread human populations.
AIDS Res. Hum. Retroviruses
12:1473-1483[Medline].
|
| 2.
|
Bieniasz, P. D.,
O. Erlwein,
A. Aguzzi,
A. Rethwilm, and M. O. McClure.
1997.
Gene transfer using replication-defective human foamy virus vectors.
Virology
235:65-72[Medline].
|
| 3.
|
Borrow, P.,
H. Lewicki,
X. Wei,
M. S. Horwitz,
N. Peffer,
H. Meyers,
J. A. Nelson,
J. E. Gairin,
B. H. Hahn,
M. B. Oldstone, and G. M. Shaw.
1997.
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CT escape virus.
Nat. Med.
3:205-311[Medline].
|
| 4.
|
Bothe, K.,
A. Aguzzi,
H. Lassmann,
A. Rethwilm, and I. Horak.
1991.
Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus.
Science
253:555-557[Abstract/Free Full Text].
|
| 5.
|
Bruce, C.,
C. Clegg,
A. Featherstone,
J. Smith, and J. Oram.
1993.
Sequence analysis of the gp120 region of the env gene of Ugandan human immunodeficiency proviruses from a single individual.
AIDS Res. Hum. Retroviruses
9:357-363[Medline].
|
| 6.
|
Coffin, J. M.
1992.
Genetic diversity and evolution of retroviruses.
Curr. Top. Microbiol. Immunol.
176:143-164[Medline].
|
| 7.
|
Coffin, J. M.
1995.
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.
Science
267:483-489.
|
| 8.
|
Falcone, V.,
J. Leupold,
J. Clotten,
E. Urbanyi,
O. Herchenröder,
W. Spatz,
B. Volk,
N. Böhm,
A. Toniolo,
D. Neumann-Haefelin, and M. Schweizer.
1999.
Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous whereas viral replication is restricted to the oral mucosa.
Virology
257:7-14[Medline].
|
| 9.
|
Felsenstein, J.
1989.
PHYLIP Phylogeny Inference Package (version 3.2).
Cladistics
5:164-166.
|
| 10.
|
Fitch, W. M., and E. Margoliash.
1967.
Construction of phylogenetic trees.
Science
155:279-284[Free Full Text].
|
| 11.
|
Flügel, R. M.,
A. Rethwilm,
B. Maurer, and G. Darai.
1987.
Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes.
EMBO J.
6:2077-2084[Medline].
|
| 12.
|
Gessain, A.,
R. C. Gallo, and G. Franchini.
1992.
Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations.
J. Virol.
66:2288-2295[Abstract/Free Full Text].
|
| 13.
|
Gessain, A.,
R. Mahieux, and G. de Thé.
1996.
Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I.
J. Acquired Immune Defic. Syndr. Hum. Retrovirology
13(Suppl. 1):132-145.
|
| 14.
|
Hahn, B. H.,
G. M. Shaw,
M. E. Taylor,
R. R. Redfield,
P. D. Markham,
S. Z. Salahuddin,
F. Wong-Staal,
R. C. Gallo,
E. S. Parks, and W. P. Parks.
1986.
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.
Science
232:1548-1553[Abstract/Free Full Text].
|
| 15.
|
Heneine, W.
1996.
The phylogeny and molecular epidemiology of human T-cell lymphotropic virus type II.
J. Acquired Immune Defic. Syndr. Hum. Retrovirology
13(Suppl. 1):236-241.
|
| 16.
|
Heneine, W.,
W. M. Switzer,
P. Sandstrom,
J. Brown,
V. Shanmugam,
C. Schable,
M. Schweizer,
D. Neumann-Haefelin,
L. E. Chapman, and T. M. Folks.
1998.
Identification of a human population endemically infected with simian foamy virus.
Nat. Med.
4:403-407[Medline].
|
| 17.
|
Herchenröder, O.,
R. Renne,
D. Loncar,
E. K. Cobb,
K. K. Murthy,
J. Schneider,
A. Mergia, and P. A. Luciw.
1994.
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV).
Virology
201:187-199[Medline].
|
| 18.
|
Hooks, J. J., and C. J. Gibbs.
1975.
The foamy viruses.
Bacteriol. Rev.
39:169-185[Free Full Text].
|
| 19.
|
Keohavong, P., and W. G. Thilly.
1989.
Fidelity of DNA polymerases in DNA amplification.
Proc. Natl. Acad. Sci. USA
86:9253-9257[Abstract/Free Full Text].
|
| 20.
|
Khanna, R.,
S. R. Burrows, and J. M. Burrows.
1997.
The role of cytotoxic T lymphocytes in the evolution of genetically stable viruses.
Trends Microbiol.
5:64-69[Medline].
|
| 21.
|
Kimura, M.
1983.
The neutral theory of molecular evolution.
Cambridge University Press, Cambridge, United Kingdom.
|
| 22.
|
Kupiec, J. J.,
A. Kay,
M. Hayat,
R. Ravier,
J. Peries, and F. Galibert.
1991.
Sequence analysis of the simian foamy virus type 1 genome.
Gene
101:185-194[Medline].
|
| 23.
|
Lamers, S. L.,
J. W. Sleasman,
J. X. She,
K. A. Barrie,
S. M. Pomeroy,
D. J. Barrett, and M. M. Goodenow.
1993.
Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo.
J. Virol.
67:3951-3960[Abstract/Free Full Text].
|
| 24.
|
Li, W. H.,
M. Tanimura, and P. M. Sharp.
1988.
Rates and dates of divergence between AIDS virus nucleotide sequences.
Mol. Biol. Evol.
5:313-330[Abstract].
|
| 25.
|
Linial, M. L.
1999.
Foamy viruses are unconventional retroviruses.
J. Virol.
73:1747-1755[Free Full Text].
|
| 26.
|
Meyerhans, A.,
R. Cheynier,
J. Albert,
M. Seth,
S. Kwok,
J. Sninsky,
L. Morfeldt-Manson,
B. Asjo, and S. Wain-Hobson.
1989.
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations.
Cell
58:901-910[Medline].
|
| 27.
|
Myers, G.,
B. Korber,
B. H. Hahn,
K.-T. Jeang,
J. W. Mellors,
F. E. McCutchan,
L. E. Henderson, and G. N. Pavlakis.
1995.
Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences.
Los Alamos National Laboratory, Los Alamos, N. Mex.
|
| 28.
|
Nestler, U.,
M. Heinkelein,
M. Lucke,
J. Meixensberger,
W. Scheurlen,
A. Kretschmer, and A. Rethwilm.
1997.
Foamy virus vectors for suicide gene therapy.
Gene Ther.
4:1270-1277[Medline].
|
| 29.
|
Neumann-Haefelin, D.,
U. Fleps,
R. Renne, and M. Schweizer.
1993.
Foamy viruses.
Intervirology
35:196-207[Medline].
|
| 30.
|
Neumann-Haefelin, D.,
A. Rethwilm,
G. Bauer,
F. Gudat, and H. zur Hausen.
1983.
Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells.
Med. Microbiol. Immunol.
172:75-86[Medline].
|
| 31.
|
Nowak, M. A.,
R. M. Anderson,
A. R. McLean,
T. F. Wolfs,
J. Goudsmit, and R. M. May.
1991.
Antigenic diversity thresholds and the development of AIDS.
Science
254:963-969[Abstract/Free Full Text].
|
| 32.
|
Pelletier, E.,
W. Saurin,
R. Chenier,
N. L. Letvin, and S. Wain-Hobson.
1995.
The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance.
Virology
208:644-652[Medline].
|
| 33.
|
Renne, R.,
E. Friedl,
M. Schweizer,
U. Fleps,
R. Turek, and D. Neumann-Haefelin.
1992.
Genomic organization and expression of simian foamy virus type 3 (SFV-3).
Virology
186:597-608[Medline].
|
| 34.
|
Rethwilm, A.
1996.
Unexpected replication ways of foamy viruses.
J. Acquired Immune Defic. Syndr. Hum. Retrovirology
13(Suppl. 1):248-253.
|
| 35.
|
Russel, D. W., and A. D. Miller.
1996.
Foamy virus vectors.
J. Virol.
70:217-222[Abstract].
|
| 36.
|
Saitou, N., and M. Nei.
1987.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
Mol. Biol. Evol.
4:406-425[Abstract].
|
| 37.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 38.
|
Schweizer, M., and D. Neumann-Haefelin.
1995.
Phylogenetic analysis of primate foamy viruses by comparison of pol sequences.
Virology
207:577-582[Medline].
|
| 39.
|
Schweizer, M.,
B. Corsten, and D. Neumann-Haefelin.
1988.
Heterogeneity of primate foamy virus genomes.
Arch. Virol.
99:125-134[Medline].
|
| 40.
|
Schweizer, M.,
R. Turek,
H. Hahn,
A. Schliephake,
K. O. Netzer,
G. Eder,
M. Reinhardt,
A. Rethwilm, and D. Neumann-Haefelin.
1995.
Markers of foamy virus (FV) infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected FV prevalence in man.
AIDS Res. Hum. Retroviruses
11:161-170[Medline].
|
| 41.
|
Schweizer, M.,
V. Falcone,
J. Gänge,
R. Turek, and D. Neumann-Haefelin.
1997.
Simian foamy virus isolated from an accidentally infected human individual.
J. Virol.
71:4821-4824[Abstract].
|
| 42.
|
Stiles, G. E.,
J. L. Bittle, and U. J. Cabasso.
1964.
Comparison of simian foamy virus strains including a new serological type.
Nature
201:1350-1351.
|
| 43.
|
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
Improved sensitivity of profile searches through the use of sequence weights and gap excision.
Comput. Appl. Biosci.
10:19-29[Abstract/Free Full Text].
|
| 44.
|
Vogt, V. M.
1997.
Retroviral virions and genomes, p. 27-69.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 45.
|
Wain-Hobson, S.
1996.
Running the gamut of retroviral variation.
Trends Microbiol.
4:135-141[Medline].
|
| 46.
|
Wang, G., and M. J. Mulligan.
1999.
Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses.
J. Gen. Virol.
80:245-254[Abstract].
|
| 47.
|
Wattel, E.,
J. P. Vartanian,
C. Pannetier, and S. Wain-Hobson.
1995.
Clonal expansion of human T-cell leukemia virus type 1-infected cells in asymptomatic and symptomatic carriers without malignancy.
J. Virol.
69:2863-2868[Abstract].
|
| 48.
|
Willems, L.,
E. Thienpont,
P. Kerkhofs,
A. Burny,
M. Mammerickx, and R. Kettmann.
1993.
Bovine leukemia virus, an animal model for the study of intrastrain variability.
J. Virol.
67:1086-1089[Abstract/Free Full Text].
|
| 49.
|
Yu, S.,
D. N. Baldwin,
S. R. Gwynn,
S. Yendapalli, and N. L. Linial.
1996.
Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses.
Science
271:1579-1582[Abstract].
|
Journal of Virology, November 1999, p. 9256-9265, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Morozov, V. A., Leendertz, F. H., Junglen, S., Boesch, C., Pauli, G., Ellerbrok, H.
(2009). Frequent foamy virus infection in free-living chimpanzees of the Tai National Park (Cote d'Ivoire). J. Gen. Virol.
90: 500-506
[Abstract]
[Full Text]
-
Delebecque, F., Suspene, R., Calattini, S., Casartelli, N., Saib, A., Froment, A., Wain-Hobson, S., Gessain, A., Vartanian, J.-P., Schwartz, O.
(2006). Restriction of Foamy Viruses by APOBEC Cytidine Deaminases. J. Virol.
80: 605-614
[Abstract]
[Full Text]
-
Jackson, A. P., Charleston, M. A.
(2004). A Cophylogenetic Perspective of RNA-Virus Evolution. Mol Biol Evol
21: 45-57
[Abstract]
[Full Text]
-
Verschoor, E. J., Langenhuijzen, S., van den Engel, S., Niphuis, H., Warren, K. S., Heeney, J. L.
(2003). Structural and Evolutionary Analysis of an Orangutan Foamy Virus. J. Virol.
77: 8584-8587
[Abstract]
[Full Text]
-
Lecellier, C.-H., Neves, M., Giron, M.-L., Tobaly-Tapiero, J., Saib, A.
(2002). Further Characterization of Equine Foamy Virus Reveals Unusual Features among the Foamy Viruses. J. Virol.
76: 7220-7227
[Abstract]
[Full Text]
-
Meiering, C. D., Maxine L. Linial,
(2001). Historical Perspective of Foamy Virus Epidemiology and Infection. Clin. Microbiol. Rev.
14: 165-176
[Abstract]
[Full Text]